P. Bouloux

597 total citations
17 papers, 471 citations indexed

About

P. Bouloux is a scholar working on Surgery, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P. Bouloux has authored 17 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P. Bouloux's work include Neuropeptides and Animal Physiology (5 papers), Adrenal and Paraganglionic Tumors (5 papers) and Hormonal Regulation and Hypertension (3 papers). P. Bouloux is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Adrenal and Paraganglionic Tumors (5 papers) and Hormonal Regulation and Hypertension (3 papers). P. Bouloux collaborates with scholars based in United Kingdom, Sweden and Italy. P. Bouloux's co-authors include G. M. Besser, Ashley Grossman, Paul Drury, Darren Wilson, Paul Hjemdahl, Tari Turner, Peter M. Price, J. R. Sutton, N. Chronos and Alison H. Goodall and has published in prestigious journals such as Nucleic Acids Research, The Journal of Clinical Endocrinology & Metabolism and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

P. Bouloux

17 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Bouloux United Kingdom 12 111 98 77 77 75 17 471
P. T. Pullan Australia 13 377 3.4× 32 0.3× 36 0.5× 113 1.5× 188 2.5× 30 774
Joanna Oświęcimska Poland 15 86 0.8× 61 0.6× 74 1.0× 80 1.0× 58 0.8× 66 637
Nasim C. Sobhani United States 9 137 1.2× 45 0.5× 87 1.1× 147 1.9× 119 1.6× 38 838
Brian Curran United States 15 68 0.6× 112 1.1× 18 0.2× 80 1.0× 85 1.1× 50 566
Jeffrey D. Roizen United States 16 97 0.9× 55 0.6× 96 1.2× 88 1.1× 83 1.1× 27 777
A. Barbarino Italy 19 640 5.8× 45 0.5× 73 0.9× 88 1.1× 202 2.7× 62 1.0k
Werner Kern Germany 13 139 1.3× 46 0.5× 29 0.4× 78 1.0× 73 1.0× 17 513
Michael J Cole Australia 14 24 0.2× 19 0.2× 68 0.9× 43 0.6× 73 1.0× 16 898
R J Abbott United Kingdom 14 48 0.4× 37 0.4× 174 2.3× 81 1.1× 27 0.4× 30 727
Robert D. Lovinger United States 11 330 3.0× 23 0.2× 53 0.7× 77 1.0× 157 2.1× 13 646

Countries citing papers authored by P. Bouloux

Since Specialization
Citations

This map shows the geographic impact of P. Bouloux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Bouloux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Bouloux more than expected).

Fields of papers citing papers by P. Bouloux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Bouloux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Bouloux. The network helps show where P. Bouloux may publish in the future.

Co-authorship network of co-authors of P. Bouloux

This figure shows the co-authorship network connecting the top 25 collaborators of P. Bouloux. A scholar is included among the top collaborators of P. Bouloux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Bouloux. P. Bouloux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Buscombe, John, et al.. (2003). Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience. Alimentary Pharmacology & Therapeutics. 17(3). 437–444. 66 indexed citations
3.
MacColl, Gavin, Christopher Bunn, G. Goldspink, P. Bouloux, & Dariusz C. Górecki. (2001). Intramuscular plasmid DNA injection can accelerate autoimmune responses. Gene Therapy. 8(17). 1354–1356. 11 indexed citations
4.
Hjemdahl, Paul, N. Chronos, Darren Wilson, P. Bouloux, & Alison H. Goodall. (1994). Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(1). 77–84. 62 indexed citations
5.
McMurray, Robert G., et al.. (1991). High-dose naloxone modifies cardiovascular and neuroendocrine function in ambulant subjects. Psychoneuroendocrinology. 16(5). 447–455. 19 indexed citations
6.
Stocks, J., et al.. (1991). Bgl-I and Kpn-I RFLPs at the human liver/islet glucose transporter (GLUT2) gene locus. Nucleic Acids Research. 19(3). 690–690. 1 indexed citations
7.
Salmon, Peter, Hannah Steinberg, Elizabeth A. Sykes, et al.. (1990). Endogenous opioids modulate the cardiovascular response to mental stress. Psychoneuroendocrinology. 15(3). 185–192. 42 indexed citations
8.
Bouloux, P., et al.. (1987). Opioid peptides and glucose metabolism. Journal of Endocrinological Investigation. 10(1). 95–104. 11 indexed citations
9.
Grossman, Ashley, et al.. (1986). Effect of an opiate antagonist on the responses of circulating catecholamines and the renin-aldosterone system to acute sympathetic stimulation by hand-grip in man. European Journal of Endocrinology. 111(2). 252–257. 12 indexed citations
10.
Bouloux, P., Ashley Grossman, & G. M. Besser. (1986). NALOXONE PROVOKES CATECHOLAMINE RELEASE IN PHAEOCHROMOCYTOMAS AND PARAGANGLIOMAS. Clinical Endocrinology. 24(3). 319–325. 15 indexed citations
11.
Firmin, Richard K., et al.. (1985). Sympathoadrenal function during cardiac operations in infants with the technique of surface cooling, limited cardiopulmonary bypass, and circulatory arrest. Journal of Thoracic and Cardiovascular Surgery. 90(5). 729–735. 21 indexed citations
12.
Bouloux, P., et al.. (1985). Erroneous Diagnosis of Phaeochromocytoma in Hypertensive Patient on Labetalol. Journal of the Royal Society of Medicine. 78(7). 588–588. 2 indexed citations
13.
Grossman, Ashley, et al.. (1985). COMPARISON OF THE CLINICAL ACTIVITY OF MESULERGINE AND PERGOLIDE IN THE TREATMENT OF HYPERPROLACTINAEMIA. Clinical Endocrinology. 22(5). 611–616. 25 indexed citations
14.
Bouloux, P., Ashley Grossman, N. Lytras, & G. M. Besser. (1985). EVIDENCE FOR THE PARTICIPATION OF ENDOGENOUS OPIOIDS IN THE SYMPATHOADRENAL RESPONSE TO HYPOGLYCAEMIA IN MAN. Clinical Endocrinology. 22(1). 49–56. 21 indexed citations
15.
Grossman, Ashley, P. Bouloux, Peter M. Price, et al.. (1984). The Role of Opioid Peptides in the Hormonal Responses to Acute Exercise in Man. Clinical Science. 67(5). 483–491. 106 indexed citations
16.
Horne, T, L. A. Hawkins, K. E. Britton, et al.. (1984). Imaging of phaeochromocytoma and adrenal medulla with 123I-meta-iodobenzyl guanidine. Nuclear Medicine Communications. 5(12). 763–768. 15 indexed citations
17.
Thorner, Michael O., Susan M. Ryan, John Wass, et al.. (1978). Effect of the Dopamine Agonist, Lergotrile Mesylate, on Circulating Anterior Pituitary Hormones in Man*. The Journal of Clinical Endocrinology & Metabolism. 47(2). 372–378. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026